The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
These vaccines have not yet been approved by the World Health Organization
Nestl India is preparing a blueprint for a possible relaunch.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
Trump also raised the possibility of using light to combat the deadly viral infection.
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Many countries found Maggi noodles to be safe for consumption.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Test reports from UP food regulator started the controversy.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
Inspections only in domestic authorities' presence, visiting US drug regulator told
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%
4 Ranbaxy facilities in India have been barred from exporting to US.
The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.
Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances